Real-World Effectiveness and Renal Safety of Foscarnet for CMV Reactivation After Allogeneic Hematopoietic Stem Cell Transplantation. (PubMed, J Clin Med) - Aug 28, 2026 - "Letermovir is used to prevent infections, but it is not available in many countries. Ganciclovir and valganciclovir carry a risk of bone marrow suppression...These findings suggest that close renal and electrolyte monitoring may be warranted. However, given the retrospective, single-center design, small sample size, and absence of a comparator group, the findings should be interpreted cautiously and confirmed in larger prospective comparative studies."
Journal • Real-world evidence • Acute Kidney Injury • Bone Marrow Transplantation • Cytomegalovirus Infection • Infectious Disease • Nephrology • Renal Disease • Transplantation
|
|
Amir Hossein Abedi; Hüseyin Saffet Beköz; Ibrahim Abdi Ali; Leylagül Kaynar; Mahmoud Alrais; Senem Maral
|